Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage
Clinical trial NCT01252160 · COMPLETED
Trial details
- NCT number
- NCT01252160
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-28
- Primary completion
- 2013-09-26
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.